Not long ago, China’s pandemic response was met with deep scepticism in the West. But fast-forward just a few years, and the picture looks very different. China’s bio-pharma industry is now booming, racing from low-cost manufacturing hub to serious contender in the global battle to create the next blockbuster drugs. China is rolling out vast new pharma facilities capable of producing next-generation medicines at a scale the West is struggling to match.
Today on The Bunker, Gavin Esler speaks to the FT’s China Technology Correspondent, Eleanor Olcott, to find out what this means for global drug development, competition, and who controls the future of medicine.
🎄Get 20% off a year’s support for The Bunker until Christmas – whether you’re a new backer, renewing or upgrading.
www.patreon.com/bunkercast
Written and presented by Gavin Esler. Producer: Liam Tait. Audio production: Robin Warren. Music by Kenny Dickinson. Artwork by James Parrett. Managing Editor: Jacob Jarvis. Group Editor: Andrew Harrison. THE BUNKER is a Podmasters Production.
www.podmasters.co.uk
Learn more about your ad choices. Visit podcastchoices.com/adchoices
